Expression of BCR-ABL, E2A-PBX1, and MLL-AF4 Fusion Transcripts in Newly Diagnosed Children with Acute Lymphoblastic Leukemia: A Children's Cancer Group Initiative
Paul S. Gaynon(University of Southern California), Fatih M. Uckun(University of Southern California), L Tuel-Ahlgren(Parker Hughes Cancer Center), Mireille Sarquis(Parker Hughes Cancer Center), Nyla A. Heerema(The Ohio State University), James B. Nachman(University of Chicago), Harland N. Sather(Children's Oncology Group), Bruce Bostrom(Minnesota West Community & Technical College), Mya Lisa Crotty, Peter G. Steinherz(Memorial Sloan Kettering Cancer Center)
Cited by 28
Related Papers
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
|Journal of Clinical Oncology|1996|920
United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia
|Journal of Clinical Oncology|2001|825